Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

Wengen Chen; Vasken Dilsizian

doi:10.2967/jnumed.119.234849

OtherHot Topics

Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

Wengen Chen and Vasken Dilsizian

Journal of Nuclear Medicine October 2019, jnumed.119.234849; DOI: https://doi.org/10.2967/jnumed.119.234849

Wengen Chen

University of Maryland School of Medicine, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vasken Dilsizian

University of Maryland School of Medicine, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

Wengen Chen, Vasken Dilsizian

Journal of Nuclear Medicine Oct 2019, jnumed.119.234849; DOI: 10.2967/jnumed.119.234849

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

Wengen Chen, Vasken Dilsizian

Journal of Nuclear Medicine Oct 2019, jnumed.119.234849; DOI: 10.2967/jnumed.119.234849

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Hot Topics

RECIP 1.0: A Roadmap for Clinical Implementation
Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA

Show more Hot Topics

Clinical (Radionuclide Therapy)

Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice

Show more Clinical (Radionuclide Therapy)

Keywords

endocrine
radionuclide therapy
research methods
hyperthyroidism
bias
cancer
radioiodine

Main menu

User menu

Search

Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Hot Topics

Clinical (Radionuclide Therapy)

Similar Articles

Keywords